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Abstract
A-T (ataxia telangiectasia) is a genetic disease caused by a mutation in the Atm (A-T mutated) gene that leads to
neurodegeneration. Despite an increase in the numbers of studies in this area in recent years, the mechanisms underlying
neurodegeneration in human A-T are still poorly understood. Previous studies demonstrated that neural stem cells (NSCs)
isolated from the subventricular zone (SVZ) of Atm
-/- mouse brains show defective self-renewal and proliferation, which is
accompanied by activation of chronic p38 mitogen-activated protein kinase (MAPK) and a lower level of the polycomb
protein Bmi-1. However, the mechanism underlying Bmi-1 down-regulation and its relevance to defective proliferation in
Atm
-/- NSCs remained unclear. Here, we show that over-expression of Bmi-1 increases self-renewal and proliferation of Atm
-/-
NSCs to normal, indicating that defective proliferation in Atm
-/- NSCs is a consequence of down-regulation of Bmi-1. We also
demonstrate that epidermal growth factor (EGF)-induced Akt phosphorylation renders Bmi-1 resistant to the proteasomal
degradation, leading to its stabilization and accumulation in the nucleus. However, inhibition of the Akt-dependent Bmi-1
stabilizing process by p38 MAPK signaling reduces the levels of Bmi-1. Treatment of the Atm
-/- NSCs with a specific p38
MAPK inhibitor SB203580 extended Bmi-1 posttranscriptional turnover and H2A ubiquitination in Atm
-/- NSCs. Our
observations demonstrate the molecular basis underlying the impairment of self-renewal and proliferation in Atm
-/- NSCs
through the p38 MAPK-Akt-Bmi-1-p21 signaling pathway.
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Introduction
ATM (A-T mutated) kinase plays a critical role in the regulation
of cell cycling, DNA repair, and cellular redox status. ATM
expression is abundant in neural stem cells (NSCs), but is gradually
reduced as the cell differentiates [1], suggesting that ATM may
play an essential role in NSC survival and function. In normal
brain tissue, the number of NSCs is the result of a tightly
controlled balance between self-renewal, proliferation, differenti-
ation and death. This means that proper control of these events is
critical for maintaining a normal numbers of neurons, astrocytes,
and oligodendrocytes in the brain [2]. The hypothesis that NSCs
are functionally defective in the absence of ATM has not been
conclusively determined. Abnormal neuronal and astrocytic
development was reported in ATM knockout mice [1], [3–5],
which could be the result of abnormal differentiation of NSCs. We
previously reported that ATM is required to maintain normal self-
renewal and proliferation of NSCs, due to its role in controlling the
redox status. Loss of ATM renders NSCs defective in proliferation
through oxidative stress-dependent p38 MAPK (hereafter called
p38) signaling [6]. However, despite the mounting interest, the
mechanisms regulating NSC survival and proliferation in response
to oxidative stress remain elusive in this mouse model.
In the present study we found that Bmi-1 is highly downreg-
ulated in Atm
-/- NSCs, or when normal NSCs are treated with
H2O2. Bmi-1 functions as a component of the polycomb repressive
protein complex [7–8]. It interacts with RING1B, another
component of polycomb repressive protein complex 1, causing
H2A ubiquitination and modification of chromatin structure
leading to epigenetically suppress gene expression [9]. In NSCs,
particularly those derived from the SVZ and hippocampus, Bmi-1
is necessary for normal NSC self-renewal and survival, because it
silences genes that encode the cell cycle inhibitors p16, p19, and
p21 [8], [10–11]. Accordingly, shRNA knockdown of bmi-1 results
in up-regulation of p21, which in turn causes suppression of NSC
self-renewal and proliferation [11]. Interestingly, Bmi-1 can also
separately regulate mitochondrial function [12] and redox
homeostasis by reducing the intracellular levels of ROS [13].
Thus, down-regulation of Bmi-1 in cells results in oxidative stress,
just as ATM deficiency does. Furthermore, Bmi-1 deficient mice
resemble Atm
-/- mice, as they exhibit oxidative stress and a
progressive postnatal depletion of NSCs that leads to neurological
abnormalities and ataxia [11–12]. Therefore, further investigation
into the mechanisms underlying Bmi-1 down-regulation in Atm
-/-
NSCs is necessary to better understand the role of ATM in
regulating self-renewal and proliferation of NSCs.
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level or the function of Bmi-1 remains unclear. Here we show that
Bmi-1 may be a substrate of Akt and up-regulation of Akt signaling
coincides with up-regulation of Bmi-1 phosphorylation and that
phosphorylated Bmi-1 is more stable. In contrast, activated
oxidative stress-dependent p38 signaling causes Bmi-1 to degrade,
and lose its chromatin modifying ability. Furthermore, we also
show that posttranscriptional regulation of Bmi-1 via proteasomal
degradation causes defective proliferation in Atm
-/- NSCs as a
result of p21 up-regulation. Collectively, these observations
strongly support the notion that down-regulation of Bmi-1 is
associated with oxidative stress-dependent pathways in Atm
-/-
NSCs with p38 activation, Akt deactivation, and p21 up-
regulation. Our findings have identified these players as potential
targets for A-T treatment.
Results
Bmi-1 is posttranscriptionally downregulated in Atm
-/-
NSCs
We previously reported that Atm
-/- NSCs display highly
decreased self-renewal and proliferation, which is correlated with
increased levels of CDK inhibitors [6]. The polycomb protein
Bmi-1 promotes NSC self-renewal and proliferation through the
repression of CDK inhibitor genes [8], [10–11], therefore we
investigated Bmi-1 levels in Atm
-/- NSCs. Atm
-/- NSCs show
decreased levels of Bmi-1 and Akt activation, which are essential
for NSC proliferation. These results are accompanied by elevated
levels of activated-p38 and p21 (Figure 1A). To investigate
whether the loss of ATM affected bmi-1 expression in NSCs,
quantitative RT-PCR analysis was performed to measure mRNA
levels. No significant decrease of bmi-1 mRNA were seen in Atm
-/-
NSCs (Figure 1B). We also examined the mRNA levels of the
CDK inhibitors p21, p16, and p19, which are regulated by Bmi-1,
and observed elevated levels of these transcripts in Atm
-/- NSCs.
This observation is consistent with studies by others that p21, p16,
and p19 expression levels are increased in bmi-1
-/- NSCs [8], [10]
or in bmi-1-knockdown NSCs [11]. The magnitude of increase in
p21 mRNA was higher than the increase seen in the mRNA levels
of p16 and p19 (Figure 1B). Using fluorescence microscopy, we
confirmed that levels of activated p38 and p21 are up-regulated,
whereas levels of activated Akt and Bmi-1 are downregulated in
Atm
-/- NSCs (Figure S1). These results indicate that the loss of
ATM causes a down-regulation in Bmi-1 protein levels in NSCs
posttranscriptionally.




-/- NSCs exhibit significantly reduced proliferation and Bmi-
1 is downregulated in these cells.
Therefore, we decided to investigate whether down-regulation
of Bmi-1 contributes to defective proliferation of Atm
-/- NSCs. To
address this question, we generated Bmi-1 over-expressing Atm
+/+
and Atm
-/- NSCs by infecting cells with a retrovirus bearing Bmi-1.
A retrovirus bearing Bmi-1 was made using a mouse stem cell virus
(MSCV) vector, which contains an internal ribosome entry site
(IRES) followed by GFP (Figure 2A) [14].
To compare the proliferative capacity of control vs. Bmi-1 over-
expressing NSCs, the number of new neurospheres, total number
of cells per well, and the size of neurospheres generated 2 days
after subculture were determined. The number of newly generated
neurosphere is indicative of NSC self-renewing activity, total cell
number in a well represents mitotic division of daughter cells in
neurosphere, and the size of newly generated neurosphere
represents proliferation within each neurosphere. As expected
and confirming the observation from our previous study [6], Atm
-/-
NSCs formed significantly lower neurosphere numbers, total cell
numbers per well, and smaller size of neurospheres compared to
Atm
+/+ NSCs. However, Bmi-1 over-expression by infecting Atm
-/-
NSCs with a retrovirus bearing Bmi-1 greatly improved newly
formed neurosphere numbers (Figure 2B), total cell numbers per
well (Figure 2C), and neurosphere size (Figure 2D). Neurosphere
number of Atm
-/- NSCs over-expressing Bmi-1 was comparable to
untreated Atm
+/+ NSCs, while neurosphere size and total cell
number were partially recovered. We also observed that Bmi-1
over-expression increased proliferation in Atm
+/+ NSCs by
increase in neurosphere numbers.
In figure 2E, photomicrographs of both Atm
+/+ and Atm
-/-
neurospheres expressing either MSCV-GFP or MSCV-GFP-Bmi-
1 are shown. The restorative action of Bmi-1 over-expression was
Figure 1. Bmi-1 is posttranscriptionally downregulated in Atm
-/- NSCs. (A) Protein samples (30 mg) from Atm
+/+ and Atm
-/- NSCs were
analyzed by Western blotting for phospho-p38, p38, phospho-Akt, Akt, Bmi-1, and p21 expression. (B) Total RNA was purified from Atm
+/+ and Atm
-/-
NSCs and subjected to quantitative RT-PCR analysis for bmi-1, p21, p16, and p19 expression. Gapdh was used as an internal control.
doi:10.1371/journal.pone.0016615.g001
ROS Accelerates Proteasomal Degradation of Bmi-1
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sphere number and size in Atm
-/- NSCs. Collectively, these results
demonstrate that NSCs require Bmi-1 for survival and normal
proliferation, and that down-regulation of Bmi-1 substantially
contributes to the defective proliferation of Atm
-/- NSCs.
Bmi-1 undergoes proteasome-mediated degradation,
which is accelerated during oxidative stress
Other researchers demonstrated that Bmi-1 expression is
modulated through transcriptional and posttranscriptional regula-
tion in hematopoietic stem cells [15]. Here, we observed no distinct
differences in bmi-1 mRNA levels between Atm
+/+ and Atm
-/- NSCs,
although decreased level of Bmi-1 protein was noted in Atm
-/- NSCs
(Figure 1). These results indicate that Bmi-1 may be downregulated
via a posttranscriptional mechanism in Atm
-/- NSCs. To determine
if the level of Bmi-1 is regulated via posttranscriptional proteasome-
mediated degradation in NSCs, we examined Bmi-1 stability in
Atm
+/+ NSCs treated with the protein synthesis inhibitor cyclohex-
imide. Cycloheximide-treated cells showed a rapid decline in Bmi-1
levels with half-life about 2 hours (Figure 3A). To investigate
whether proteasome inhibitionaffects the levelsof endogenous Bmi-
1, NSCs were treated with proteasome inhibitor MG132.
Treatment of cells with MG-132 significantly increased Bmi-1
levels compared to those in untreated cells (Figure 3B). In addition,
co-treatment with MG-132 and cycloheximide slowed the degra-
dation of Bmi-1, compared to single treatment with cycloheximide
(Figure 3C). These results indicate that Bmi-1 turn over can be
antagonized by proteasome inhibition.
We have previously demonstrated that excess ROS elicited by
H2O2 treatment decreased NSC proliferation through activation
of p38 signaling, similar to that in Atm
-/- NSCs [6]. Therefore, to
ascertain whether oxidative stress could also affect Bmi-1
degradation, we treated Atm
+/+ NSCs with H2O2 and analyzed
Bmi-1 and p21 levels. Western blot analysis revealed that Bmi-1
appears as a triplet of approximately 40 to 44-kDa. Currently, no
specific antibody is available to detect the phosphorylated form of
Bmi-1, thus phosphorylation is determined by mobility shift. After
1 hour of treatment with H2O2, the unphosphorylated Bmi-1
band was significantly reduced (faster migration on gel), resulting
in an increase in the phosphorylated bands (slower migration on
gel), compared to those of untreated samples. After 4 hours of
incubation with H2O2, we observed a dramatic reduction in the
Figure 2. Down-regulation of Bmi-1 causes defective proliferation in Atm
-/- NSCs. (A) Generation of Bmi-1 over-expressing NSCs by
infecting Atm
+/+ or Atm
-/- NSCs with MSCV-GFP-bmi-1 bearing retrovirus. (B) Neurosphere number generated by control and Bmi-1 over-expressing
Atm
+/+ and Atm
-/- NSCs. (C) Total cell number per well generated by control and Bmi-1 over-expressing Atm
+/+ and Atm
-/- NSCs. (D) Neurosphere size
generated by control and Bmi-1 over-expressing Atm
+/+ and Atm
-/- NSCs. (B-D) The mean6S.E. of three independent experiments is shown.
Np,0.05;
NNp,0.01, when GFP-Bmi-1 expressing Atm
+/+ NSCs were compared with GFP expressing Atm
+/+ NSCs, when GFP-Bmi-1 expressing Atm
-/- NSCs were
compared with GFP expressing Atm
-/- NSCs, or when GFP expressing Atm
-/- NSCs were compared with GFP expressing Atm
+/+ NSCs. (E) Phase-contrast
photomicrographs of Atm
+/+ and Atm
-/- neurospheres, either expressing MSCV-GFP or MSCV-GFP-Bmi-1. Scale bars =50 mm.
doi:10.1371/journal.pone.0016615.g002
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untreated sample), as well as a significant reduction in the level of
Bmi-1 (Figure 3D). In addition, H2O2 caused a significant increase
in p21 protein levels in NSCs. Interestingly, H2O2 selectively
caused a significant elevation in p21 expression, whereas
expression of bmi-1, p16, and p19 were not altered in H2O2-
treated NSCs (Figure 3 E). The reason of the selectivity of p21
expression by oxidative stress is unclear. However, it can be
explained by the previous study demonstrating that p21 protects
cells from oxidative damage through activation of Nrf2 as an
antioxidant response [16], and it was also shown that Bmi-1 is
important for NSC proliferation and survival at earlier embryonic
stages, via suppression of cell cycle inhibitor p21, potentially with
stage-related differences [11].
The result as shown above that Bmi-1 is posttranscriptionally
downregulated in response to H2O2 (Figure 3D and E) prompted
us to examine whether oxidative stress causes a change in Bmi-1
turnover. Wild-type NSCs were co-treated with H2O2 and
cycloheximide. We observed that H2O2 dramatically shortens
Bmi-1 half-life (Figure 3F), whereas the p38 inhibitor SB203580
slowed this rapid degradation of Bmi-1 (Figure 3G), suggesting
that the H2O2-induced rapid degradation of Bmi-1 is a p38-
dependent pathway. This finding is consistent with our previous
observation that oxidative stress reduces proliferation of NSCs
through p38 signaling [6]. Collectively, these results demonstrate
that Bmi-1 undergoes proteasome-mediated degradation, and that
oxidative stress elicited by H2O2 accelerates Bmi-1 degradation
through p38 signaling in NSCs.
Figure 3. Bmi-1 undergoes proteasome-mediated degradation, which is accelerated during oxidative stress. (A) Atm
+/+ NSCs were
treated for the times indicated with cycloheximide (50 mg/mL) and Bmi-1 levels were determined by Western blotting. Probing with an antibody to b-
actin was used as a loading control. The values represent the Bmi-1 signal intensity compared to the 0 h time point. (B) Atm
+/+ NSCs were treated for
the times indicated with MG132 (10 nM) and Bmi-1 levels were determined by Western blotting. Probing with an antibody to b-actin was used as a
loading control. The values represent the Bmi-1 signal intensity compared to the 0 h time point. (C) Atm
+/+ NSCs were co-treated for the times
indicated with cycloheximide (50 mg/mL) and MG132 (10 nM), and Bmi-1 levels were determined by Western blotting. Probing with an antibody to b-
actin was used as a loading control. The values represent the Bmi-1 signal intensity compared to the 0 h time point. (D) NSCs from Atm
+/+ mice were
treated for the times indicated with 100 mMH 2O2 with the addition of MG132 (10 nM), and Bmi-1 and p21 levels were determined by Western
blotting. (E) NSCs from Atm
+/+ or Atm
-/- mice were treated for 7 hours with 100 mMH 2O2 and total RNA was purified and analyzed by quantitative RT-
PCR analysis for bmi-1, p21, p16, and p19 expression. Probing for gapdh was used as an internal control. (F) NSCs from Atm
+/+ mice were treated for
the times indicated with cycloheximide (50 mg/mL) and 100 mMH 2O2, and Bmi-1 levels were determined by Western blotting. Probing with an
antibody to b-actin was used as a loading control. The values represent the Bmi-1 signal intensity compared to the 0 h time point. (G) NSCs from
Atm
+/+ mice were pretreated with 10 mM SB203580 for 2 hours before treated for the times indicated with cycloheximide (50 mg/mL), and Bmi-1
levels were determined by Western blotting. Probing with an antibody to b-actin was used as a loading control. The values represent the Bmi-1 signal
intensity compared to the 0 h time point.
doi:10.1371/journal.pone.0016615.g003
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phosphorylation and up-regulation in NSCs
Neurosphere formation and NSC proliferation are dependent
on EGF (Epidermal growth factor) through signaling by the EGFR
(Epidermal Growth Factor Receptor) tyrosine kinase [17].
Therefore, we investigated if signaling by EGF had functional
consequences on the proteasomal degradation of Bmi-1. First, the
phosphorylation state of Akt was analyzed to evaluate the activity
of the phosphoinositide-3-kinase (PI3-K) signaling pathway after
EGF treatment. We observed that Akt is activated shortly after
EGF treatment in EGF-starved Atm
+/+ NSCs and activation is
inhibited by PI3-K inhibitor, LY2949002 (Figure 4A). Because
Bmi-1 represses gene expression of CDK inhibitors through H2A
ubiquitination and promotes NSC proliferation [18–19], we
examined the effects of EGF treatment on H2A ubiquitination.
H2A ubiquitination was reduced during EGF-starvation, but was
restored when EGF was added back to the culture (Figure 4B)
coincided with Akt activation, indicating that H2A ubiquitination
by Bmi-1 requires EGF-Akt signaling. Next, we examined whether
EGF-Akt signaling affects Bmi-1 levels and found that Akt
activation by EGF treatment coincided with Bmi-1 up-regulation.
We also investigated if Bmi-1 up-regulation by EGF correlates
with phosphorylation by Akt. To verify the phosphorylation status
of Bmi-1, we treated the protein extracts with l phosphatase, a
Ser/Thr and Tyr phosphatase. We found that phosphorylation of
Bmi-1 (slower migration on the gel) was increased by EGF
treatment and was eliminated by l phosphatase as evidenced by
faster migration on the gel (Figure 4C), indicating that Bmi-1 is a
phosphoprotein. Collectively, these results imply that Bmi-1 up-
regulation and its function in histone H2A ubiquitination is
dependent on Akt signaling in NSCs. We next questioned whether
Akt is involved in Bmi-1 phosphorylation, thus we performed an
amino acid sequence analysis to identify Bmi-1 phosphorylation
sites (http://www.scansite.edu). Since Bmi-1 contains a predicted
Akt substrate motif, we decided to determine if Bmi-1 is a substrate
for Akt. Bmi-1 purified by immunoprecipitation from NSCs was
detected by anti-phospho (Ser/Thr) Akt substrate antibody.
However, it was less detectable by anti-phospho (Ser/Thr) Akt
substrate antibody in NSCs treated with LY294002 (data not
shown), suggesting that Bmi-1 may be a substrate of Akt.
In Atm
+/+ NSCs, Bmi-1 is highly expressed and localizes in the
nucleus. Bmi-1 levels were reduced under EGF-starvation condi-
tions or after treatment with LY2949002 (Figure 4D, upper panels),
further suggesting Akt-dependent Bmi-1 up-regulation. In the
presence of EGF stimulus, Bmi-1 localizes in chromatin of glioma
stem cells (GSCs), evidenced by the fact that Bmi-1 in GSCs co-
localizes with histone H3 in the immunocytochemistry image (data
not shown). However, EGF-starvation significantly abolishes Bmi-1
nuclear accumulation and the LY2949002 partially blocks Bmi-1
nuclear accumulation (Figure 4D, lower panels). These results
suggest that Bmi-1 nuclear localization is also an Akt-dependent
process. Our results demonstrate that Akt signaling causes Bmi-1
phosphorylation in NSCs resulting in up-regulation of Bmi-1.
Bmi-1 is downregulated by p38 signaling during
oxidative stress through Akt inhibition
We have previously reported that H2O2 highly decreases NSC
proliferation, and that the p38 inhibitor, SB203580, restores
normal proliferation [6]. In the present study we showed that
H2O2 decreased Bmi-1 levels in NSCs (Figure 3D), therefore we
asked whether the inhibition of p38 signaling by SB203580 rescues
Bmi-1 levels even under oxidative stress conditions. We observed
that H2O2 down-regulates Bmi-1 in Atm
+/+ NSCs, but SB203580
to some extent restores Bmi-1 levels in H2O2-treated NSCs.
Restorative effects were not observed after treatment with the PI3-
K inhibitor LY2949002, nor ERK1/2 inhibitor PD98059
(Figure 5A). Since p21 expression was selectively increased by
H2O2-treatment in Atm
+/+ NSCs (Figure 3E), we also questioned
whether p38 inhibition by SB203580 has an effect on p21
expression in H2O2-treated NSCs. As expected, no distinct
differences in bmi-1, p16, and p19 expression were observed in
H2O2-treated NSCs. p21 expression significantly increased in
response to H2O2 treatment, but the p38 inhibitor, SB203580,
highly reduced p21 expression (Figure 5B), further indicating that
during oxidative stress Bmi-1 down-regulation and its functional
consequence are a p38 dependent process.
The existence of cross talk between p38 MAPKs and the PI3K/Akt
and/or ERK survival pathways has also been described in other
cellular systems. For example, activation of p38 MAPKs inhibits the
PI3K/Akt and/or ERK pathways through activation of PP2A
phosphatases [20–22]. In the present study, we showed Akt pathway
stabilizes Bmi-1 (Figure 4). However, negative regulation of Akt by p38
in NSCs and the relevance of this cross talk in the Bmi-1 regulation are
unclear. Therefore, we decided to investigate whether negative
regulation of Bmi-1 by p38 could be linked to Akt and/or PP2A
regulation. We treated Atm
+/+ NSCs with okadaic acid, a PP2A
i n h i b i t o ro rw i t hl phosphatase, a Ser/Thr and Tyr phosphatase. We
expected that okadaic acid would increase Akt phosphorylation
becausePP2Ais known todephosphorylate Akt. However weobserved
that okadaic acid decreased Akt phosphorylation levels. In contrast,
okadaic acid triggered phosphorylation of both p38 and Bmi-1. This
result indicates that p38 negatively regulates Akt via PP2A in NSCs,
and that Bmi-1 is phosphorylated by an Akt-independent mechanism.
On the other hand, treatment of protein extract with l phosphatase
dephosphorylated p38 and Akt, as well as Bmi-1 (Figure 5C). These
results suggest that there might be an inhibitory cross talk between p38
and Akt as they show opposite activation events by okadaic acid and
implies the relevance of Akt inhibition by PP2A in the down-regulation
of Bmi-1 induced by p38 activation.
Interestingly, okadaic acid treatment has similar effects on p38,
Akt, and Bmi-1 with H2O2 treatment, eliciting p38 and Bmi-1
phosphorylation and Akt dephosphorylation (compare with
Figure 5D, at 1 hour). These results suggest that although Bmi-1
contains no known p38 phosphorylation motif (http://www.
scansite.edu), p38 may also phosphorylate Bmi-1 when Akt is
unable to phosphorylate Bmi-1 under oxidative stress conditions.
To further link p38/Akt to Bmi-1 stability, we asked whether the
proteasome inhibitor MG132 prevents H2O2-induced p38 phos-
phorylation and restores levels of Akt phosphorylation and Bmi-1
expression. We treated Atm
+/+ NSCs with H2O2 for 1 or 7 hours.
Bmi-1 levels were decreased at 1 hour and barely detected at
7 hours. In contrast, MG132 stabilized Akt phosphorylation,
coinciding with Bmi-1 up-regulation and phosphorylation
(Figure 5D). These observations indicate that the Akt-dependent
phosphorylation of Bmi-1 results in its up-regulation by inhibiting
the proteasome-dependent degradation process. Interestingly,
MG132 downregulates p38 activation levels (Figure 5D) and
SB203580 restored Bmi-1 levels in H2O2-treated Atm
+/+ NSCs
(Figure 5A). Collectively, these results demonstrate that during
oxidative stress, Bmi-1 is downregulated by p38-mediated
proteasomal degradation through Akt inhibition.
p38 signaling leads to proteasomal degradation of Bmi-1
in Atm
-/- NSCs
We compared the phosphorylation status of Bmi-1 in protein
extracts from Atm
+/+ and Atm
-/- NSCs after treatment with l
phosphatase. Bmi-1 phosphorylation was unimpaired regardless of
ROS Accelerates Proteasomal Degradation of Bmi-1
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Atm
-/- NSCs (Figure 6A). This phenomenon might be explained by
the fact that under normal conditions Akt is primarily responsible
for phosphorylating Bmi-1, but in Atm
-/- NSCs, p38 is still capable
of phosphorylating Bmi-1 in an ATM-independent manner. Next,
we sought to determine whether up-regulation of Bmi-1 and Akt
signaling correlated with inhibition of Bmi-1 proteasomal
degradation. We treated Atm
+/+ and Atm
-/- NSCs with MG132
for 4 hours to monitor Akt activation and Bmi-1 levels. We found
that MG132 treatment increased Akt activation and Bmi-1 levels
in both cells, and that Akt activation by MG132 treatment was
accompanied by increased Bmi-1 levels. In addition, the levels of
Akt activation and Bmi-1 expression in Atm
-/- NSCs treated with
MG132 were comparable to levels in MG132-treated Atm
+/+
Figure 4. EGF-mediated Akt signaling causes Bmi-1 phosphorylation and up-regulation in NSCs. (A) Atm
+/+ NSCs were deprived of
epidermal growth factor (EGF, 20 ng/ml) for 4 hours, at which time EGF was added back to the cultures for indicated times, with or without addition
of LY2949002 (LY, 10 mM), and analyzed by Western blotting for phospho-Akt and Akt levels. (B) After EGF starvation of Atm
+/+ NSCs for 4 hours, EGF
was added back to the cultures for 3 hours. Neurospheres were analyzed by Immunocytochemistry for the levels of ubiqutinated-histone H2A (H2A-
Ub) and phospho-Akt. Cells were counterstained by DAPI (49-6-Diamidino-2-phenylindole), which identifies the nuclei of the NSCs. (C) After EGF
starvation of Atm
+/+ NSCs for 4 hours, EGF was added back to the cultures for 3 hours and analyzed for levels of phospho-Akt, Akt, and Bmi-1 by
Western blotting. Protein samples (30 mg) were then treated in vitro with l phosphatase (Ser/Thr and Tyr phosphatase) for 1.5 hours and analyzed for
changes in migration of Bmi-1 in SDS-PAGE. Arrowhead indicates totally dephosphorylated forms of Bmi-1 that can be used as the reference band to
visualize the mobility shift of Bmi-1 (faster migration on gel). (D) Atm
+/+ NSCs and GSCs were deprived of EGF for 4 hours. EGF was added back to the
cultures for 3 hours, with or without LY2949002. Bm-1 levels and localization were analyzed by Immunofluorescence (FITC-green). Cells were
counterstained by DAPI (49-6-Diamidino-2-phenylindole), which identifies the nuclei of the NSCs.
doi:10.1371/journal.pone.0016615.g004
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regulation in NSCs occurs by proteasomal degradation and Akt
signaling protects Bmi-1 from proteasomal degradation.
We analyzed an Akt activation profile in Atm
+/+ and Atm
-/-
NSCs after exposure to H2O2. We found that Atm
-/- NSCs, but not
Atm
+/+ NSCs, failed to activate Akt after exposure to H2O2 (data
not shown), demonstrating that ATM is required for the activation
of Akt. In the absence of ATM, Bmi-1 phosphorylation by Akt is
reduced, which might accelerate the p38-dependent degradation
of Bmi-1. Notably, treatment of Atm
-/- NSCs with SB203580
restored Akt activation and normal proliferation [6], which implies
that in Atm
-/- NSCs, Bmi-1 degradation may be accelerated by
chronic p38 activation. To address this hypothesis we treated
Atm
+/+ and Atm
-/- NSCs with cycloheximide, to block de novo
synthesis of Bmi-1 and the half-life of Bmi-1 was compared by
Western blotting analysis. Next, to confirm that Bmi-1 degradation
is linked to p38 signaling in Atm
-/- NSCs, we treated Atm
-/- NSCs
with SB203580 and calculated the half-life of Bmi-1 as compared
to untreated NSCs. We observed that the half-life of Bmi-1 in
Atm
-/- NSCs was shortened compared to Atm
+/+ NSCs, but
SB203580 extended the turnover of Bmi-1 in Atm
-/- NSCs
(Figure 6C). We also found that Bmi-1 levels and H2A
ubiquitination are reduced in Atm
-/- NSCs compared to Atm
+/+
NSCs. Inhibition of p38 signaling by SB203580 significantly
restored these levels in Atm
-/- NSCs (Figure 6D). Taken together
with the up-regulation of p38 signaling and the down-regulation of
Akt signaling in Atm
-/- NSCs (Figure 1A), these results demonstrate
that in Atm
-/- NSCs p38-mediated proteasomal degradation of
Bmi-1 is accelerated compared to normal NSCs.
Discussion
The majority of previous investigations examining A-T
associated neurodegeneration have focused on neurons and
Figure 5. Bmi-1 is downregulated by p38 signaling during oxidative stress through inhibiting Akt. (A) Atm
+/+ NSCs were pretreated for
2 hours with either LY2949002 (LY, 10 mM), PD98059 (PD, 10 mM), or SB203580 (SB, 10 mM), and then treated for 4 hours with 100 mMH 2O2. Protein
samples were analyzed by Western blotting fo levels of phospho-p38, p38, phospho-Akt, Akt, and Bmi-1. (B) Atm
+/+ NSCs were pretreated for 2 hours
with SB203580 (SB, 10 mM) and then treated for 4 hours with 100 mMH 2O2. Total RNA were purified and analyzed by quantitative RT-PCR analysis for
bmi-1, p21, p16, and p19 expression. Probing for gapdh was used as an internal control. (C) Atm
+/+ NSCs were treated for 4 hours with okadaic acid
(OA, PP2A inhibitor) or 100 mMH 2O2. Protein samples (30 mg) were treated in vitro with l phosphatase for 1.5 hours and analyzed by Western
blotting for levels of phospho-p38 and p38, phospho-Akt, Akt, and Bmi-1. (D) Atm
+/+ NSCs were treated with 100 mMH 2O2 for times indicated in the
presence or absence of 10 mM MG132, and analyzed by Western blotting for levels of phospho-p38 and p38, phospho-Akt, Akt, and Bmi-1.
doi:10.1371/journal.pone.0016615.g005
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targeting holds the prospect to provide a cure for many
neurodegenerative diseases, as NSCs possess the potential to
differentiate into neurons, oligodendrocytes, and astrocytes.
Because of their pluripotency, impairment of NSCs likely results
in neuronal cell loss in Atm
-/- mice. We previously demonstrated
that NSCs from SVZ of Atm
-/- mouse brain are abnormal, in terms
of decreased proliferative capacity and lower Bmi-1 expression
levels compared to Atm
+/+ NSCs [6].
Here we show that down-regulation of Bmi-1 contributes to
defective self-renewal and proliferation in Atm
-/- NSCs because
over-expression of Bmi-1 restores Atm
-/- NSC proliferation to
normal (Figure 2). Additionally, we identified upstream effectors
that control Bmi-1 levels and function in chromatin modifica-
tion. Our data suggests that p38 is a central player in the
defective proliferation of Atm
-/- NSCs induced by oxidative
stress. Previous report demonstrated that p38 participates in p21
up-regulation, subsequently resulting in cell growth inhibition
[23]. Here, we show that Bmi-1 levels are regulated post-
transcriptionally by proteasome-mediated degradation (Figure 3).
In addition, EGF-mediated Akt activation is associated with
Bmi-1 stabilization (Figure 4), and the p38 inhibitor, SB203580,
also stabilizes Bmi-1 in H2O2-treated NSCs and Atm
-/- NSCs
(Figure 3, 5, and 6). We conclude that in the absence of ATM,
chronic oxidative stress results in the activation of p38, leading to
inhibition of the Akt-dependent Bmi-1 stabilizing process, thus
causing Bmi-1 to degrade more rapidly. It is also possible that
p38 downregulates Bmi-1’s ability to bind to chromatin, thus
Bmi-1 loses its suppressive effects on p21, which is supported by
our findings that the p38 inhibitor, SB203580, restores H2A
ubiquitination (Figure 6C) and restores p21 levels in Atm
-/- NSCs
[6].
Figure 6. p38 signaling leads to proteasomal degradation of Bmi-1 in Atm
-/- NSCs. (A) Protein samples (30 mg) from Atm
+/+ or Atm
-/- NSCs
were treated in vitro with l phosphatase for 1.5 hours and analyzed by Western blotting for changes in migration of Bmi-1 in SDS-PAGE. (B) Atm
+/+ or
Atm
-/- NSCs were treated for 4 hours with 10 mM MG132 and phospho-Akt, Akt, and Bmi-1 levels were determined by Western blotting. (C) Atm
-/-
NSCs were pretreated with 10 mM SB203580. Atm
+/+ and Atm
2/2 NSCs were then treated for times indicated with cycloheximide (50 mg/mL) and Bmi-
1 levels were determined by Western blotting. Probing with an antibody to b-actin was used as a loading control. The values represent the Bmi-1
signal intensity compared to the 0 h time point. (D) Atm
+/+ or Atm
-/- NSCs treated for 24 hours with either cultured in simple medium (middle panel)
or 10 mM SB203580 (right panel) were analyzed by Immunofluorescence for Bmi-1, phospho-p38, and ubiqutinated-histone H2A (H2A-Ub). Cells were
counterstained by DAPI (49-6-Diamidino-2-phenylindole), which identifies the nuclei of the NSCs.
doi:10.1371/journal.pone.0016615.g006
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the centromeres [24]. Furthermore, Bmi-12chromatin association
has been proven by immunostaining [25–26]. However, mecha-
nisms regulating Bmi-1 chromatin association are still unclear. We
performed biochemical fractionation of Bmi-1 to see differential
chromatin association and found that more Bmi-1 chromatin
association is seen in Atm
+/+ NSCs than in Atm
-/- NSCs (data not
shown). In normal condition, Bmi-1 chromatin association is
strictly regulated by its phosphorylation status in the cell cycle [26–
27]. Therefore, our data might be explained by the fact that Atm
-/-
NSCs show abnormal Akt and p38. We have proven that
abnormal p38-Akt signaling contributes to defective NSCs
proliferation and self-renewal [6]. Another interesting question
to be addressed is whether or not Akt/p38-dependent Bmi-1
phosphorylation is critical for its chromatin association.
It is unclear if Bmi-1 is a p38 substrate from our study, but it has
been reported that Bmi-1 could be phosphorylated by 3pk
(MAPKAP kinase 3), which is a downstream effector of p38
[26]. Phosphorylation of Bmi-1 by 3pk reduces Bmi-1’s ability to
bind to chromatin, thus reducing its suppressive effect on p21.
Another way in which p38 may regulate Bmi-1 levels is via down-
regulation of Akt because Bmi-1 restoration by the p38 inhibitor,
SB203580, is accompanied by an increase in Akt activation levels
under oxidative stress conditions (Figure 5). This result is
supported by another report that describes the oxidative stress-
induced activation of p38, which attenuates insulin-like growth
factor stimulation of Akt [28]. Our studies also show that Bmi-1 is
a substrate of Akt, and up-regulation of p-Akt coincides with up-
regulation of p-Bmi-1. Until now, no one has shown that Akt can
phosphorylate and up-regulate Bmi-1. Therefore, this will be the
first time a direct functional link between Akt and Bmi-1 is made.
Further study is under way to make their direct links. The
connection between the p38/Akt signaling and Bmi-1 stability in
A-T is a newly described angle of ATM signaling that may be
relevant to clinical aspects of the this disease.
Protein kinase activities are redox-sensitive because key cysteine
residues in these proteins can undergo posttranslational modifica-
tions by oxidants [5]. It has recently been shown that H2O2 is
directly responsible for disulfide bond formation, which results in a
conformational alteration and activation of ATM [29]. This
suggests that ATM can be activated in response to increased ROS
levels to regulate the redox status of the cells, independently of its
response to DNA damage [30]. Our findings demonstrate that in
the absence of ATM, chronic oxidative stress results in activation
of the p38-Bmi-1-p21 pathway in NSCs. Taken together, we
propose a possible mechanism regulating Bmi-1 stability by Akt or
p38 signaling (Figure 7). We hypothesize that a function of ATM is
to act as a redox modulator. As a consequence of increased ROS
levels p38 is activated, which may block the Akt-dependent Bmi-1
stabilizing process. This event accelerates proteasome-mediated
degradation of Bmi-1, which in turn upregulates p21 and
suppresses proliferation (red arrow). During normal condition,
EGF-mediated Akt phosphorylation leads to Bmi-1 stabilization
and neural stem cell proliferation (green arrows). By controlling
p38 or Akt signaling, which has yin and yang effects on Bmi-1
stability, we may be able to control Atm
-/- NSC proliferation as
described in the above mechanism.
NSCs possess a range of actions that can be potentially used for
therapy, because they are capable of self-renewal and can
differentiate into cells of glial and neuronal lineages in the CNS
[31–32]. Bmi-1 is also important for maintenance of NSC
multipotency, which is required for generating neurons [11],
[33], and Bmi-1 overexpression increases neurogenic capacity of
NSCs [14]. Previous studies demonstrated that normal p38
signaling is essential for NSC differentiation [34] and activated
p38 leads to abnormal differentiation in NPC1
-/- (The Niemann-
Pick type C1) NSCs [35]. We show here that Atm
-/- NSCs have
abnormally activated p38 and lower level of Bmi-1 compared to
Atm
+/+ NSCs. We also observed that Atm
-/- NSCs are capable of
undergoing multilineage differentiation, but they show different
frequencies of differentiated cells when compared to Atm
+/+ NSCs.
(data not shown). Therefore, we hypothesize that abnormal p38–
Bmi-1 signaling in Atm
-/- NSCs may affect their neurogenic
capacity, which would change the fate of the progenitor cells.
Continuing our investigation, it will be still interesting to examine
the fate of the progenitor cells to astroglia, oligodendroglia, and
neurons by assessing the frequency of multilineage cells from
Atm
+/+ and Atm
-/- NSCs, and to determine whether p38 signaling
inhibition affects the neurogenic capacity of Atm
-/- NSCs.
In recent years, NSC transplantation has proven to be a more
tractable therapeutic strategy for neurodegenerative disorders than
the conventional placement of differentiated neurons, since NSCs
can replace many cell types, not just one, and can synergize with
other therapies, including drug treatments [31–32], [36]. When
NSCs are defective, as they are in Atm
-/- mice, transplanting
normal Atm
+/+ NSCs may rescue impaired NSCs by restoring
homeostasis to the NSCs themselves, or by stabilizing normal
metabolism and redox balance in the supporting cell microenvi-
ronment. The imposition of ‘‘molecular homeostasis’’ may be the
basis for this NSC rescue. Here we show that Atm
-/- NSCs have
abnormally reduced levels of Bmi-1, and we know that Bmi-1 is
necessary for improved NSC survival and proliferation. Thus, our
Figure 7. Proposed mechanism underlying defective prolifer-
ation of Atm
-/- NSCs. Bmi-1 expression is regulated mainly through
posttranscriptional mechanism by proteasomal degradation. EGF-
mediated Akt phosphorylation renders Bmi-1 resistant to the degrada-
tion process, leading to its stabilization and neural stem cell
proliferation (green arrows). However, chronic oxidative stress, in the
absence of ATM, activates p38 signaling blocks Akt-dependent Bmi-1
stabilizing, resulting in accelerated proteasome-mediated degradation
of Bmi-1 and p21 up-regulation, which in turn may suppress
proliferation (red arrow).
doi:10.1371/journal.pone.0016615.g007
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insight for development of stem cell-based novel therapies in
human patients with A-T or with other genetic deficiencies that
lead to neurodegeneration. Transplantation of normal Atm
+/+
NSCs into Atm
-/- mouse brains may thus promote a return to
normal levels of Bmi-1 in the Atm
-/- NSCs. In future studies, we
will develop a reliable NSC transplantation system to ask two
questions. First, is Atm
+/+ NSC transplantation into the cerebella of
Atm
-/- mice followed by a functional recovery of Atm
-/- NSC and
restore the normal cerebella architecture? Second, can Atm
+/+
NSC transplantation alter p38 signaling and gene expression





-/- mice were originally generated by Dr. C. Barlow.
They were purchased from the Jackson Laboratory (Bar Harbor,
ME). We genotyped offspring of Atm
+/– breeding pairs by real-time
polymerase chain reaction–based assays of mouse tail DNA.
Littermates were used as controls in all experiments. Animal care
was in accordance with The University of Texas MD Anderson
Cancer Center guidelines for animal experiments.
NSC isolation and neurosphere culture
Neurospheres were obtained from P1 pup SVZ, and were
maintained in culture essentially as reported [37]. The walls of the
lateral ventricles were removed and enzymatically dissociated in
HBSS buffer (5 mM KCl, 124 mM NaCl, 3.2 mM MgCl2,
100 mM CaCl2, 26 mM NaHCO3, and 10 mM glucose) contain-
ing 1 mg/ml trypsin at 37uC for 10 minutes. The tissue was
centrifuged at 750 rpm for 5 minutes in soybean trypsin inhibitor.
The dispersed cells were then resuspended in HBSS buffer
containing 0.7 mg/ml RNase free DNase and enzymatically
disaggregated for 5 minutes at room temperature. The dissociated
cells were centrifuged, resuspended in Neural Basal Medium
(NBM) containing 20 ng/ml EGF, 10 ng/ml FGF, 2 mM
glutamine, antibiotics (100 units/ml penicillin and 100 g/ml
streptomycin), and 0.125 mg/ml fungizone, and maintained in
an atmosphere of 5% CO2,a t3 7 uC. After 1–2 days of incubation,
the cells formed neurospheres. Subcultures were prepared every
4–5 days by centrifugation of the neurospheres and dissociation of
the cells in 1 ml of trypsin; then, the single-cell suspensions were
replated in new culture dishes in fresh medium, to obtain new
neurospheres. Experiments were performed with cultured cells
between passages 2 and 5. GSCs were developed by Dr. F. Lang
(MD Anderson Cancer Center) and were kindly provided by Dr.
O. Bogler (MD Anderson Cancer Center). GSCs culture condition
was same with Atm
+/+ and Atm
-/- NSCs as described above.
Chemical reagents
The PI3K inhibitor LY294001 (10 mM), the p38 MAPK
inhibitor SB203580 (10 mM), the ERK inhibitor PD98059
(10 mM), MG132 (10 mM), and Okadaic acid (10 mM), were
purchased from BD Biosciences. Lambda phosphatase was
purchased from New England Biolabs. Transcription inhibitor
cycloheximide (50 mg/ml) was purchased from Sigma-Aldrich.




Bmi-1 bearing retrovirus was made using a mouse stem cell virus
(MSCV) vector MSCV-GFP-Bmi-1 (kindly provided by Dr.
Morrison, University of Michigan), which contains an internal
ribosome entry site (IRES) followed by GFP [14]. Preparationof the
virus was carried out by transfection of 293T packaging cells with
the MSCV-GFP-Bmi-1 vector. 293T cells were allowed to produce
virus for 24–48 hours, then cell supernatants were collected, 0.2
micron filtered, and stored at 280uC or used fresh to infect cultured
NSCs. To generate Bmi-1 over-expressing Atm
+/+ and Atm
-/- NSCs,
neonatal subventricular zone (SVZ) tissue from wild type or Atm
deficient mice was dissected, dissociated, and cultured as described
above. NSCs were plated at 20,000 cells per well of a six-well plate.
After 24–48 hours, virus-containing supernatant was added to NSC
cultures for 16 hours. The culture medium was then replaced for
24 hours, and cells were trypsinized and re-plated for tests of
proliferative capacity. Before proliferative capacity assays, MSCV-
GFP-Bmi-1 expression in cells was assessed by fluorescence
microscopy.
Cell proliferation assays
After trypsinizing neurospheres, single neural stem cells were
resuspended in NBM containing 20 nM EGF and 20 nM FGF.
The cells were then seeded into 96-well plates at a density of 10
2
cells per well, to allow cell communication by paracrine/autocrine
factors for physiological proliferation. After incubation for
48 hours, the numbers of newly formed neurospheres per well
were counted, using phase contrast microscopy. To measure
neurosphere sizes, images were obtained from 3 separate fields per
well, and the volumes of neurospheres estimated using a
microimage analysis system from Olympus. To measure total cell
proliferation in neurospheres, cells in each well were trypsinized,
and total cell numbers per well were counted.
Immunocytochemical image analysis
Neurospheres were seeded on 2– or 8– well chamber slides
coated with poly-L-lysine/lamin, and then incubated for 3 hours,
to facilitate adhesion. These cells, which will be referred to as
‘‘adhered neurospheres’’ in the text, maintained the properties of
undifferentiated cells, as evidenced by anti-nestin staining.
Adhered neurospheres also respond to H2O2 in a manner similar
to the floating neurospheres. For ROS response experiments,
neurospheres in monolayer cultures were treated with H2O2 in
NBM for 16 hours, after which the cells were fixed with 4%
paraformaldehyde in PBS for 30 minutes at room temperature,
and permeabilized with 0.1% Triton X-100 in PBS for 15
minutes. For staining with antibodies, the cells were preincubated
for 2 hours at 37uC with 10% FBS in PBS, and then further
incubated at 4uC overnight with primary antibodies. The
antibody-bound cells were washed three times in PBS for 5
minutes each, and fluorescent secondary antibodies were added
for 1 hour at 37uC. Nuclei were stained with 49, 6-diamidino-2-
phenylindole (DAPI). The stained slides were then mounted in
Slowfade (Molecular Probes). Cells were imaged under an
Olympus IX2-SL microscope, equipped with a 6400 objective
and an Olympus DP 70 digital camera connected to a PC
computer.
Protein analysis
For protein measurement, cells were seeded into 10-cm dishes,
and treated with drugs or H2O2. At indicated times after
treatment, cells were collected and washed once with ice-cold
PBS and then resuspended into lysis buffer containing 150 mM
NaCl, 0.5% w/v sodium dodecyl sulfate (SDS), 0.5% v/v NP-40,
0.5% w/v sodium deoxycholate, 1 mM EGTA, and a mixture of
protease inhibitors (Complete Mini tablets; Boehringer Mann-
heim). For Western blotting, protein concentrations were deter-
mined using a Bradford reagent (BioRad). Proteins (30 mg) were
separated by SDS-polyacrylamide gel electrophoresis on 10% gels,
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incubation with primary antibodies.
Antibodies
Antibodies used for Western blotting analysis were anti-
phospho-Akt (Ser473), anti-Akt, anti-phospho-p38 (Th180/
Tyr182), anti-p38, anti-ubiquitinated histone H2A, anti-Akt
substrate (Cell Signaling Technology); anti-p21 and anti-b-actin
(Santa Cruz Biotechnology); anti-Bmi-1 (Millipore Co.).
Quantitative RT-PCR




quantified, relative to gapdh, internal RNA control, by quantitative
RT-PCR. Sequences of PCR primers are listed as follows. Primers
that amplified bmi-1: Mm03053308_g1. Primers that amplified
p21Cip1: cdkn1a (p21): Mm00432448_m1. Primers that amplified
p16Ink4a: Mm01257348_m1. Primers that amplified p19Arf were
designed: sense, 59-GGGCCGCACCGGAAT-39 and antisense,
59-AAGAGCTGCTACGTGAACGT-39.
Statistics
For each experiment, data are presented as the mean 6 S.E. of
values. Each experiment was repeated at least three times.
Statistical comparisons of values for Atm
+/+ vs. Atm
-/- neurospheres,
and for untreated control vs. treated neurospheres were made
using an analysis of variance (ANOVA), followed by Bonferroni’s
post hoc test. Differences were considered significant when p,0.05.
Analyses of data were performed using Prism 5 Software
(GraphPad Software, Inc. San Diego, CA).
Differentiation of neural stem cells
Neurospheres were enzymatically dissociated as described
above. The cells were seeded on to chamber slides, and then
maintained in medium containing 10% FBS, without EGF and
FGF for 7 days. Antibodies used for characterization of neural
stem cells were anti-Map2 (Cell Signaling Technology), anti-
GFAP (Santa Cruz Biotechnology).
Supporting Information




-/- neurospheres were analyzed for phospho-p38, phos-
pho-Akt, Bmi-1, and p21 by Immunofluorescence. Cells were
counterstained by DAPI (49-6-Diamidino-2-phenylindole), which
identifies the nuclei of the NSCs.
(DOC)
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